Skip to main content
OpenTrials

Clinical trial condition

Pharyngeal Diseases

Explore clinical trials studying Pharyngeal Diseases. Study availability and eligibility vary by location and protocol.

1,560 public trials 361 recruiting studies
Refine in advanced search Browse all conditions

Pharyngeal Diseases trial results

Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

NCT07195734

Conditions
Carcinoma, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +33 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sutter Medical Center Sacramento Sacramento, California, United States
View all 102 locations
View Trial Details
Recruiting

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

NCT06457503

Conditions
Head and Neck Neoplasms, Nasopharyngeal Cancer Recurrent, Nasopharyngeal Diseases, +8 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Irvine Irvine, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

NCT06064097

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +14 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 85 locations
View Trial Details
Recruiting

Biospecimen Procurement for Head and Neck Disorders

NCT03429036

Conditions
Ear Diseases, Head and Neck Neoplasms, Hearing Disorder, +18 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Hospital Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • George Washington University Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Hospital Broadway Baltimore Baltimore, Maryland, United States
View Trial Details
Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 225 locations
View Trial Details
Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

NCT05172245

Conditions
Carcinoma, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +43 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View all 18 locations
View Trial Details
Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

NCT06589804

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +38 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Fremont - Rideout Cancer Center Marysville, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • UCHealth Memorial Hospital Central Colorado Springs, Colorado, United States
View all 192 locations
View Trial Details
Recruiting

The Minimalist Trial-2

NCT06702033

Conditions
HPV-Related Oropharynx Squamous Cell Carcinoma, Head and Neck Neoplasms, Neoplasms, +7 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • Sanford Roger Maris Cancer Center Fargo, North Dakota, United States
  • Sanford Cancer Center Sioux Falls, South Dakota, United States
View Trial Details

Related conditions